Delta‐He as a Novel Predictive and Prognostic Biomarker in Patients With NSCLC Treated With PD–1/PD‐L1 Inhibitors

Delta‐He as a Novel Predictive and Prognostic Biomarker in Patients With NSCLC Treated With PD–1/PD‐L1 Inhibitors

ABSTRACT Background Lung cancer treatment has rapidly advanced, particularly with immune checkpoint inhibitors (ICIs) targeting PD‐1 and PD‐L1. However, there are variable responses, such as immune‐related adverse events. Several factors predicting the prognosis of lung cancer ICI treatment have bee...

Full description

Saved in:
Bibliographic Details
Main Authors: Green Hong, Song‐I Lee, Da Hyun Kang, Chaeuk Chung, Hee Sun Park, Jeong Eun Lee
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Cancer Medicine
Subjects:
Delta‐he
immune checkpoint inhibitors
NSCLC
PD‐1/PD‐L1 inhibitors
Online Access:https://doi.org/10.1002/cam4.70826
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items